Windward Bio AG
- Address
- Steinentorstrasse 23
Sponsor Overview
Specializations
Respiratory medicine
Windward Bio AG focuses on asthma, with clinical research centered on moderate and severe asthma in adult participants. The sponsor’s current work reflects interest in treatment areas where persistent airway inflammation and symptom control remain clinically important.
- Asthma
- Moderate asthma
- Severe asthma
The research landscape is concentrated in respiratory therapeutics, with active study sites across multiple countries and collaboration spanning several clinical centers.
Immunology and biologic response
Clinical activity includes evaluation of immunogenicity, indicating interest in immune responses relevant to biologic or targeted therapies used in chronic airway disease.
- Immunogenicity
- Immune-mediated response
- Biologic therapy assessment
This area supports research into how immune activity may influence treatment performance in asthma management.
Clinical pharmacology
The sponsor’s trial portfolio includes assessment of pharmacokinetics, reflecting attention to how investigational therapy is absorbed, distributed, and cleared in adults with respiratory disease.
- Pharmacokinetics
- Drug exposure
- Systemic disposition
These interests align with development work in targeted respiratory treatments and their behavior in clinical use.
Safety and tolerability
Windward Bio AG also studies safety, tolerability, and efficacy in the context of chronic airway disease, with attention to how investigational therapy is received by adults living with persistent asthma.
- Safety
- Tolerability
- Efficacy
The company’s activity is concentrated in a single respiratory program involving a network of 33 research sites across 5 countries.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of WIN378 (Human IgG1 Monoclonal Antibody Against TSLP) in Adults with Moderate to Severe Asthma |  Bulgaria France Germany Spain Sweden | Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 31 sites across their trial portfolio.
Therapeutic Focus
- 1.Respiratory Tract Diseases1 trial277 other sponsors
Partnered Research Centres
31 centres- Address
- 1 Rue Jean Burguet, 33000 Bordeaux
- Address
- 14 Rue Paul Gaffarel, 21000 Dijon
- Address
- 80 Avenue Augustin Fliche, 34295 Montpellier
- Address
- 1 Place Alexis Ricordeau, 44000 Nantes
- Address
- Boulevard De La Chantourne, Cs 10217, La Tronche, 38043 La Tronche
- Address
- Brigadgatan 26, 587 58 Linköping
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Windward Bio AG.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.